Wincyp Syrup is a combination pharmaceutical formulation containing Cyproheptadine (2mg/5ml) and Tricholine Citrate (275mg/5ml), designed to provide therapeutic benefits in the management of allergic conditions and support liver function. Cyproheptadine is a potent antihistamine with antiserotonergic properties, effectively alleviating symptoms associated with allergic reactions such as rhinitis, urticaria, and pruritus by blocking histamine H1 receptors. Additionally, it may stimulate appetite in certain clinical scenarios. Tricholine Citrate acts as a choleretic agent, promoting bile secretion and enhancing liver detoxification processes, thereby supporting hepatic function and aiding in the metabolism of fats. The syrup formulation allows for ease of administration, particularly in pediatric and geriatric populations. Wincyp Syrup is indicated for patients requiring relief from allergic manifestations alongside hepatic support, especially in cases where appetite stimulation is desired. Dosage should be individualized based on patient age, weight, and clinical condition, and it is essential to adhere to prescribed guidelines to minimize potential adverse effects such as drowsiness, dry mouth, or gastrointestinal disturbances. Contraindications include hypersensitivity to any component, and caution is advised in patients with hepatic impairment or glaucoma. Consultation with a healthcare professional is recommended prior to use.